BIO-TECHNE Corp — Director's Dealing 2015

Apr 2, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2015-03-31

Reporting Person: Hippel James (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-31	Common Stock	M	1666	—	Acquired	1666	Direct
2015-03-31	Common Stock	F	566	$100.29	Disposed	1100	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-31	Restricted Stock Units	$	M	1666	Disposed		Common Stock (1666)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$86.25	2021-04-01	Common Stock (25000)	25000	Direct
Stock Option (Right to Buy)	$86.25	2021-04-01	Common Stock (10000)	10000	Direct
Stock Option (Right to Buy)	$94.35	2021-08-12	Common Stock (35000)	35000	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.

F2: On April 1, 2014, the reporting person was granted 5,000 restricted stock units, vesting in three equal annual installments beginning on March 31, 2015.

F3: Vests 6,250 shares on each of April 1, 2015, April 1, 2016, April 1, 2017 and April 1, 2018.

F4: This performance based stock option award will vest if, and only if, certain performance goals are achieved, which performance goals will be established by the Executive Compensation Committee within 60 days of the grant date.

F5: Vests 8,750 shares on each of August 12, 2015, August 12, 2016, August 12, 2017 and August 12, 2018.